(Q53084808)

English

The effect of timing of maternal tetanus, diphtheria, and acellular pertussis (Tdap) immunization during pregnancy on newborn pertussis antibody levels - a prospective study.

scientific article published on 28 August 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/25173476

The effect of timing of maternal tetanus, diphtheria, and acellular pertussis (Tdap) immunization during pregnancy on newborn pertussis antibody levels - a prospective study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/25173476

0 references

1 reference

based on heuristic

inferred from title

author name string

Bahaa Abu Raya

1

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/25173476

Isaac Srugo

2

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/25173476

Aharon Kessel

3

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/25173476

Michael Peterman

4

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/25173476

David Bader

5

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/25173476

Ron Gonen

6

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/25173476

Ellen Bamberger

7

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/25173476

language of work or name

0 references

publication date

28 August 2014

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/25173476

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/25173476

32

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/25173476

44

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/25173476

5787-5793

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/25173476

Epidemic pertussis in 2012--the resurgence of a vaccine-preventable disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.038

7 January 2021

California pertussis epidemic, 2010.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.038

7 January 2021

The case for maternal vaccination against pertussis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.038

7 January 2021

Effect of a Prepregnancy Pertussis Booster Dose on Maternal Antibody Titers in Young Infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.038

7 January 2021

Maternal immunization with tetanus-diphtheria-pertussis vaccine: effect on maternal and neonatal serum antibody levels

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.038

7 January 2021

Immune responses in infants whose mothers received Tdap vaccine during pregnancy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.038

7 January 2021

Importance of timing of maternal combined tetanus, diphtheria, and acellular pertussis (Tdap) immunization and protection of young infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.038

7 January 2021

Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.038

7 January 2021

Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.038

7 January 2021

What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.038

7 January 2021

Natural history of pertussis antibody in the infant and effect on vaccine response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.038

7 January 2021

A prime time for trained immunity: innate immune memory in newborns and infants.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.038

7 January 2021

Innate immunity in human newborn infants: prematurity means more than immaturity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.038

7 January 2021

Skewed pattern of Toll-like receptor 4-mediated cytokine production in human neonatal blood: low LPS-induced IL-12p70 and high IL-10 persist throughout the first month of life.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.038

7 January 2021

Pertussis disease burden in the household: how to protect young infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.038

7 January 2021

The influence of maternal immunization on infant immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.038

7 January 2021

Low levels of antipertussis antibodies plus lack of history of pertussis correlate with susceptibility after household exposure to Bordetella pertussis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.038

7 January 2021

A search for serologic correlates of immunity to Bordetella pertussis cough illnesses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.038

7 January 2021

Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.038

7 January 2021

Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.038

7 January 2021

The protective role of maternally derived antibodies against Bordetella pertussis in young infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.038

7 January 2021

The relationship between concentration of specific antibody at birth and subsequent response to primary immunization.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.038

7 January 2021

Kinetics of the Antibody Response to Tetanus-Diphtheria-Acellular Pertussis Vaccine in Women of Childbearing Age and Postpartum Women

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.038

7 January 2021

Maternal-fetal transport of immunoglobulin G and its subclasses during the third trimester of human pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.038

7 January 2021

The transmission of immunity from mother to young and the catabolism of immunoglobulins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.038

7 January 2021

Fetal and maternal immunoglobulin levels during pregnancy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.038

7 January 2021

Pertussis: a matter of immune modulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.038

7 January 2021

Pertussis toxin and adenylate cyclase toxin: key virulence factors of Bordetella pertussis and cell biology tools

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.038

7 January 2021

Isolation and properties of the leukocytosis- and lymphocytosis-promoting factor of Bordetella pertussis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.038

7 January 2021

Bordetella pertussis pathogenesis: current and future challenges

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.038

7 January 2021

Pertussis pathogenesis--what we know and what we don't know

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.038

7 January 2021

Predictors of death in infants hospitalized with pertussis: a case-control study of 16 pertussis deaths in Canada

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.038

7 January 2021

Pathology and pathogenesis of fatal Bordetella pertussis infection in infants.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.038

7 January 2021

Biological activities of crystalline pertussigen from Bordetella pertussis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.038

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2014.08.038

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/25173476

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/25173476

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53084808&oldid=1382150813"